產品名稱 |
Dengue virus type 1 |
商品貨號 |
B162832 |
Classification |
Flaviviridae, Flavivirus |
Agent |
Dengue virus type 1 |
Strain |
Hawaii |
Applications |
Vector-borne disease research |
Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Product Format |
frozen 1.0 mL per vial |
Storage Conditions |
-70°C or colder |
Images |
|
Comments |
Derived by adaptation of mouse-prepared product ATCC® VR-1254™ to Vero cells (ATCC® CCL-81™). ATCC® VR-1254™ and ATCC® VR-1856™ have not been compared for sequence or infectivity in tissue culture and in vivo. |
Effect on Host |
CPE, refractile rounding and sloughing |
Recommended Host |
Vero cells (ATCC® CCL-81™) |
Growth Conditions |
Temperature: 33°C
Recommendations for Infection: Plate cells 18-24 hours prior to infection and infect when cultures are 80-90% confluent. Remove medium and inoculate with a small volume of virus (e.g., 1 mL per 25 cm2) diluted to provide an optimal MOI (e.g., 0.02). Adsorb 1-2 hours at 33°C in a humidified 5% CO2 atmosphere. End adsorption by adding virus growth medium.
Incubation: 7-15 days at 33°C in a humidified 5% CO2 atmosphere, until CPE is progressed through 80% of the monolayer. |
Name of Depositor |
R Selvarangan, Children’s Mercy Hospital |
Source |
Pooled serum from 6 patients, Hawaii, 1944 |
References |
Sabin AB. . Science 101: 640, 1945.
Sabin AB. Viral and Rickettsial Infections of Man. Philadelphia: JB Lippincott Co; 1959.
|